Business

FDA Identifies Most Needed Meds to Address Urgent Medical Conditions

This action was in response to an executive order issued on August 6, 2020 aimed at protecting the public against outbreaks of emerging diseases and chemical, biological, radiological, and nuclear threats.

IT Asset Inventories Are a First Step in Securing Health Information

Practices need to know all of the components of their health information systems to determine potential vulnerabilities.

The Rising Incidence of Burnout Among Mental Health Professionals

Burnout is on the rise among psychiatrists. Explore the driving factors behind this trend and learn key interventions to avoid its negative effects.

Ethical Considerations in Prescribing Unproven Therapies for COVID-19

Meeting public demand for an urgently needed effective medication quickly and safely during a pandemic involves difficult tradeoffs.

The Psychology of Collecting Debt: How to Get Patients to Pay Their Bills

By connecting on a personal level, medical practices may have better results in getting patients to settle their accounts.

Protecting Practices From Ransomware

Hackers have penetrated healthcare providers’ computer systems to encrypt information and demand money for its release.

The Twitter Effect on How Oncologists Conduct and Share Research

The social media platform can be useful as an education tool for oncologists to stay up to date on new research in oncology — but physicians still need to be mindful of the information sources.

Reinventing Primary Care: Lessons Learned From the COVID-19 Pandemic

The CDC’s framework created to address the influenza pandemic of 2014 is an efficient structure for primary care practices to implement for future pandemics following COVID-19.

DEA Warns of Extortion Scam Targeting Healthcare Providers

The DEA has issued a warning concerning an extortion scam involving calls from someone purporting to be a DEA agent attempting to extort money.

Sex Differences in Income Vary With Proportion of Male Doctors

For surgical and nonsurgical specialists, sex differences in income vary with the proportion of male physicians in a practice.

Prepare to E-Prescribe Controlled Substances

Beginning January 1, 2021, a federal law called the Every Prescription Conveyed Securely Act takes effect requiring that prescriptions for controlled substances covered under Medicare be prescribed electronically.

Financial Health of Hospitals ‘Dire’ Due to COVID-19

COVID-19 continues to cause financial peril for US hospitals.

Keeping Health Information Secure in the Cloud

Putting information in the cloud can be a good move for a physician’s practice — but only if done well.

Family Medicine Resident Graduates Remain in the Field

Family medicine residency graduates continue to practice in the field after residency.

Seven Tips for Managing Healthcare Teamwork During a Pandemic

COVID-19 has brought unprecedented stress to society at large and perhaps most of all to frontline healthcare teams in a variety of settings. We spoke to an expert about teamwork during such trying times.

Can Advocacy Groups Provide Useful Patient-Centered Data?

A survey presented during ASCO20 found that patients who considered themselves adequately informed felt “in control” most days.

Large Losses Anticipated for Primary Care Practices in 2020

Primary care practices are estimated to lose more than $67,000 in gross revenue per full-time physician over the course of 2020 due to COVID-19.

Boosting Income During the COVID-19 Crisis

Finding ways to increase patient volume and cut costs can improve practices’ bottom lines.

Back to Basics: Focus on Risk Assessments for HIPAA Compliance

Regardless of the challenges a smaller group might have, a risk assessment is a baseline for any HIPAA program. The cost of this assessment is considerably less than a HIPAA fine.

FDA: Emergency Use Authorization Revoked for Chloroquine, Hydroxychloroquine

The FDA has revoked the emergency use authorization for chloroquine phosphate and hydroxychloroquine sulfate based on emerging data suggesting that these agents are unlikely to be effective against COVID-19.